Drug Trial Radar · NCT05942625
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Oct 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
84
Planned (sponsor's estimate)
Start
May 23, 2023
Primary completion
Jun 30, 2024
Study completion Dec 30, 2024
Sponsor
- Lead sponsor
- Hansoh BioMedical R&D CompanyIndustry
- Sponsor type
- Industry
- First posted
- Jul 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this first in human study is to evaluate the safety, tolerability, pharmacokinetics (PK),and pharmacodynamics (PD) of HS-10390 in healthy subjects.
Conditions
- IgA Nephropathy
- Focal Segmental Glomerulosclerosis
Interventions
HS-10390 tabletDrug
Oral administration of specified dose of HS-10390
Placebo tabletDrug
Oral administration of matching dose ofplacebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity and association with the study drug of adverse events (AEs), serious AEs (SAEs), and AEs leading to discontinuationTime frame: Day 1 up to Day 12 (SAD), Day 1 up to Day 28 (MAD)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongda Hospital, Affiliated to Southeast University
Nanjing, Jiangsu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.